Endo Pharmaceuticals Solutions Inc. v. Custopharm Inc.
1:14-cv-01422
Overview
Parties
Defendant
Paddock Laboratories LLC Operating Company
Represented By
7 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Bayer Pharma AG NPE (Individual / Inventor)
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Bayer Intellectual Property GmbH Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Claimant
Custopharm Inc. Operating Company
Represented By
7 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Perrigo Company NPE (Individual / Inventor)
Represented By
4 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Counter Defendant
Endo Pharmaceuticals Solutions Inc. NPE (Patent Assertion Entity)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,718,640 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,338,395 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 45,431,203 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7718640
Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
|
Filed: 2004-03-12
Issued: 2010-05-18
|
Expiring Soon (114 days)
+1097d PTA
Expires: 2027-03-14
|
|
|
US8338395
Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
|
Filed: 2009-02-24
Issued: 2012-12-25
|
Expiring Soon (169 days)
Expires: 2027-05-08
|
Patent Enforceability & Injunction Risk Assessment
Narrowing Window — Less than 6 months of enforceable term remains. Courts rarely grant preliminary or permanent injunctions when term expiration is imminent.
High PTA (+1097 days) / Cellect Scrutiny — Over 1097 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
6
Dispositive
0
Granted
0
Denied
0
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings